scispace - formally typeset
H

Henry Masur

Researcher at National Institutes of Health

Publications -  414
Citations -  56261

Henry Masur is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Pneumocystis carinii & Pneumonia. The author has an hindex of 105, co-authored 402 publications receiving 52273 citations. Previous affiliations of Henry Masur include Burroughs Wellcome Fund & Memorial Sloan Kettering Cancer Center.

Papers
More filters
Journal ArticleDOI

The interaction in vitro of Pneumocystis carinii with macrophages and L-cells.

TL;DR: A role for antibody and mononuclear phagocytes during the immune response to Pneumocystis is suggested, suggesting a role for antibodies andmononuclearphagocytes in the response of rat-derived cells and humoral factors.
Journal ArticleDOI

Drug Interactions in Patients Infected with Human Immunodeficiency Virus

TL;DR: This AIDS Commentary has succinctly reviewed the current state of knowledge regarding the potential for additive or synergistic drug interactions that can result in enhanced toxicity or, alternatively, augmented therapeutic benefit in patients with AIDS.
Journal ArticleDOI

The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases.

TL;DR: The clinical records and autopsy data of 75 patients dying with AIDS were reviewed to determine the frequency of individual diseases diagnosed premortem and postmortem, the significance of pulmonary processes found in the lungs at autopsy, and the clinical and pathologic causes of death.
Journal ArticleDOI

Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.

TL;DR: It is suggested that early detection and initiation of therapy may improve chances for survival, and important prognostic information can be derived from information obtained at initial presentation and follow-up bronchoscopic evaluation in patients with AIDS and Pneumocystis carinii pneumonia.
Journal ArticleDOI

Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America.

TL;DR: These practice parameters presume that any unexplained temperature elevation merits a clinical assessment by a healthcare professional that includes a review of the patient's history and a focused physical examination before any laboratory tests or imaging procedures are ordered, and address how to evaluate a new fever in an adult patient already in the ICU.